Biogen Inc. - BIIB
About Gravity Analytica
Recent News
- 06.17.2025 - Biogen Annual Stockholder Meeting
- 06.17.2025 - Biogen Annual Stockholder Meeting
- 06.12.2025 - Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity
- 06.12.2025 - Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity
- 06.12.2025 - Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity
- 06.11.2025 - Biogen Investor Pipeline Series – Felzartamab and Rare Disease
- 06.11.2025 - Biogen Investor Pipeline Series – Felzartamab and Rare Disease
- 06.11.2025 - Biogen Investor Pipeline Series – Felzartamab and Rare Disease
- 06.11.2025 - Biogen Investor Pipeline Series – Felzartamab and Rare Disease
- 06.11.2025 - Biogen Highlights the Potential of Felzartamab for a Range of Immune-Mediated Diseases Including Three Phase 3 Programs in Rare Kidney Diseases